MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
Part of paid clinical trials in Hershey, Pennsylvania.
- Sponsor
- Milton S. Hershey Medical Center
- Study ID
- NCT05937594
- Status
- Recruiting
Conditions
- Neonatal Abstinence Syndrome
- Neonatal Opioid Withdrawal Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 5 Days
- Healthy Volunteers
- Not accepted
Interventions
- Buccal swab saliva for further genetic testing — GENETICGenetic testing. Whole saliva RNA will be isolated for downstream microRNA quantification.
Study Details
Infants with neonatal abstinence syndrome (NAS) experience prolonged hospital stays and poor neurodevelopmental outcomes, in-part because of the lack of accurate, individualized, biologic assessments available to manage this increasingly common medical condition. The proposed study will define the molecular mechanisms that regulate the response to opioid withdrawal in the developing brain by focusing on three candidate microRNAs (let-7a, miR-146a, miR-192) that have been shown to respond to opioid exposure in animal models and adults, and are impacted in both my preliminary study of infants with NAS, and my human neural progenitor cell (NPC) design of opioid withdrawal. By determining the mechanism through which microRNAs impact NPC differentiation in opioid withdrawal, and determining whether exosomal salivary microRNA levels predict treatment dose and neurodevelopmental outcomes in infants with NAS, this study will enhance our knowledge of NAS-related biology and identify potential biomarkers that could improve medical care for this important medical condition.
Key Dates
- Start date
- Jan 15, 2020
- Status verified
- Jan 2026
- Primary completion
- Dec 10, 2026
- Completion
- Apr 10, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Infants exposed to in utero opiatesInfants that meet IRB-approved inclusion/exclusion criteria.
Primary Outcome Measure
Neurodevelopmental outcome scores [ Time Frame: 6 months of age ]
Central Contacts
- Rhea E Sullivan, B.S.717-531-0003
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | - |
Find similar trials in Hershey, PA
Related Studies
- An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal SyndromeRecruiting · HELP for NOWS Consortium · Birmingham, Alabama
- Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection ProcessEnrolling By Invitation · Rekovar Inc. · Albuquerque, New Mexico